GSK3B and Cognitive impairment: After 3 weeks of oral gavage with IRN (20 or 40 mg/kg/day), Aβ25-35-induced cognitive impairment was improved in rats, and inhibition of GSK3β activity was one of the mechanisms (Xian et al., 2014).